Regional Urology, LLC
Shreveport, Louisiana 71106-8150
0 studies enrolling now · 56 studies all time
What they study most
Adenocarcinoma of the Prostate, Advanced Prostate Cancer, Benign Prostatic Hyperplasia, Benign Prostatic Hypertrophy, Bladder Cancer, Castration-Resistant Prostate Cancer, Castration-Resistant Prostatic Neoplasms, Chronic Prostatitis With Chronic Pelvic Pain Syndrome, Cystitis, Interstitial, Dietary Hyperoxaluria, Erectile Dysfunction, Fractures
Studies at this site
- Optilume™ BPH Catheter System in Men With Symptomatic BPH — Running, not enrolling
- A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT — Running, not enrolling
- BlueWind RENOVA iStim™ System for the Treatment of OAB — Completed
- Composur: Study to Understand the Performance of Vibegron in Participants with Overactive Bladder (OAB) — Completed
- Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer — Completed
- Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia — Completed
- Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) — Completed
- A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer — Stopped early
- RF Ablation of the Trigone for the Treatment of UUI — Paused
- Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia) — Completed
- A Study of Galeterone Compared to Enzalutamide In Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic CRPC — Stopped early
- A Study to Evaluate Androderm®'s Effect on Blood Pressure in Adult Hypogonodal Male Participants — Completed
- PSD502 in Subjects With Premature Ejaculation — Completed
- A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease — Stopped early
- A Study of Cetrelimab (JNJ-63723283), a Programmed Cell Death Receptor-1 (PD-1) Inhibitor, Administered in Combination With Apalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer — Completed
- Study of VERU-944 to Ameliorate Hot Flashes in Men With Advanced Prostate Cancer — Completed
- A Pilot Study of Oxalate Absorption in Secondary Hyperoxaluria — Completed
- BOTOX® Intravesical Instillation in Participants With Overactive Bladder and Urinary Incontinence — Completed
- A Study To Investigate Tanezumab In Patients With Interstitial Cystitis/ Painful Bladder Syndrome — Stopped early
- Prospective US Radiofrequency SUI Trial — Status unconfirmed
- Uphold LITE Post-Market Surveillance Study — Completed
- An Efficacy And Safety Study Of Tanezumab For The Treatment Of Pain Associated With Chronic Abacterial Prostatitis — Completed
- An Effectiveness and Safety Study of PF-04383119 for the Treatment of Pain in Interstitial Cystitis — Completed
- Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-611) — Completed
- An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB). — Completed
- A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB) — Completed
- Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer — Stopped early
- Evaluation of the 2005 AMS (American Medical System) IPP (Inflatable Penile Prosthesis) — Completed
- A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer — Completed
- Safety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer — Completed
- A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine. — Completed
- Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer — Completed
- Efficacy and Tolerability of an Intra-Nasal Testosterone Product — Completed
- PASCUAL (Prostate Assay Specific Clinical Utility at Launch) Study — Stopped early
- Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism — Completed
- Efficacy of an Intranasal Testosterone Product — Completed
- A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome — Completed
- OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder — Completed
- Study of AA4500 in the Treatment of Peyronie's Disease — Completed
- Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days — Completed
- Efficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder Cancer — Stopped early
- An Extension Study Investigating the Efficacy and Safety of a Fast-Dissolving ("Melt") Formulation of Desmopressin for the Treatment of Nocturia in Adults — Completed
- Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men — Status unconfirmed
- Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia — Completed
- Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis — Stopped early
- Study Evaluating the Safety, Tolerability, and Efficacy of Dexmecamylamine (TC-5214) for Treatment of Overactive Bladder — Completed
- Exploratory Study of Pagoclone in Men With Premature Ejaculation. — Completed
- R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence — Status unconfirmed
- Evaluation of the Coloplast Titan® IPP for Maintaining Penile Length While Treating Erectile Dysfunction (ED) — Completed
- Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy — Completed